Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search

Print

2021 RESEARCH

- Archives -

Limiting screen time for young adults after concussion results in shorter duration of symptoms

Limiting screen time for young adults after concussion results in shorter duration of symptoms

Newly published research by Theodore E. Macnow, MD, shows that young adults who limited screen time for 48 hours immediately after suffering a concussion had a significantly shorter duration of symptoms than those who were permitted screen time.

Behind the research: Jae-Hyuck Shim strives to unlock cure for devastating childhood bone disease

Behind the research: Jae-Hyuck Shim strives to unlock cure for devastating childhood bone disease

Jae-Hyuck Shim, PhD, is inspired to develop a gene therapy for fibrodysplasia ossificans progressiva (FOP) after seeing the strength of families who have a child with the rare, crippling disease.

COVID-19 vaccine benefits pregnant women and babies, UMMS faculty say

COVID-19 vaccine benefits pregnant women and babies, UMMS faculty say

The benefits of the COVID-19 vaccine for pregnant women and their babies are backed by solid, ongoing research, according to UMass Medical School faculty.

Helmsley Charitable Trust grant to fund UMMS IBD diet research

Helmsley Charitable Trust grant to fund UMMS IBD diet research

With the funding, Ana Maldonado-Contreras, PhD, will tailor a novel diet created at UMass Medical School to patients in Puerto Rico with different food availability and preferences.

Communicating science: Institute for Drug Resistance video series elevates awareness, understanding

Communicating science: Institute for Drug Resistance video series elevates awareness, understanding

In a new video series, UMass Medical School scientists explain their research to address the global health challenge of drug resistance. In the first video of the series, Medicines Designed to Last, Celia Schiffer, PhD, sets the stage with a straightforward overview of drug resistance.

Two new studies from Daryl Bosco lab shed new light on ALS mechanisms

Two new studies from Daryl Bosco lab shed new light on ALS mechanisms

Two studies from the lab of Daryl Bosco, PhD, offer new insights into the biochemical and molecular mechanisms that cause amyotrophic lateral sclerosis.

UMMS researchers take at-home COVID-19 testing to the streets in community enrollment events

UMMS researchers take at-home COVID-19 testing to the streets in community enrollment events

Several times a week, UMass Medical School researchers offer Worcester-area residents the opportunity to enroll in some of the studies conducted for COVID-19 Test Us.

No Lyme vaccine yet, but antibody shot could provide seasonal immunity

No Lyme vaccine yet, but antibody shot could provide seasonal immunity

Mark Klempner, MD, provides an update to a piece originally published last year on The Conversation about a yearly antibody for Lyme disease that shows promise for preventing infection.

COVID vaccine trial for kids on track, says KidCOVE principal investigator at UMMS

COVID vaccine trial for kids on track, says KidCOVE principal investigator at UMMS

Moderna’s TeenCOVE and KidCOVE mRNA COVID-19 vaccine clinical trials are on track to expand the number of children in the Moderna KidCOVE trial, as requested this week by the Food and Drug Administration.

Guangping Gao and Dan Wang partner with ASC Therapeutics to develop novel gene therapy for maple syrup urine disease

Guangping Gao and Dan Wang partner with ASC Therapeutics to develop novel gene therapy for maple syrup urine disease

UMass Medical School researchers Guangping Gao, PhD, and Dan Wang, PhD, are working with ASC Therapeutics to bring a gene therapy for maple syrup urine disease (MSUD) to the clinic.

Showing 1-10 of 67 items
of 7